{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:58:34Z","timestamp":1790859514966,"version":"4.1.0"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer-related mortality worldwide. Despite the clinical success of immune checkpoint inhibitors, a substantial proportion of patients exhibit primary resistance, largely attributable to the immunosuppressive \u201ccold\u201d tumor microenvironment (TME). Saikosaponin D (SSd), a triterpenoid saponin derived from Bupleurum falcatum L., has emerged as a multifaceted immunomodulator with potential to remodel the TME, yet its role in converting \u201ccold\u201d HCC to an immunologically responsive \u201chot\u201d phenotype remains systematically unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review proposes a hypothesis-generating framework for saikosaponin D mediated cold-to-hot immune conversion in hepatocellular carcinoma. We synthesize preclinical evidence and integrate it into a dynamic temporal model to guide future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, EMBASE, Web of Science, and Cochrane Library from January 2020 to December 2025. Search terms included saikosaponin D, hepatocellular carcinoma, and immunomodulation. The search was broadened to solid tumor immunology due to limited hepatocellular carcinoma specific studies. Two investigators screened and extracted data. From 306 initial records, 139 publications were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Saikosaponin D modulates multiple signaling pathways including PI3K\/AKT\/mTOR, STAT3, HIF-1\u03b1, and TGF-\u03b2. It may promote immunogenic cell death, dendritic cell maturation, T-cell recruitment, macrophage repolarization, and metabolic remodeling. We propose a four-stage temporal model of immune conversion. Low oral bioavailability and missing orthotopic validation are key challenges that nanoformulation and organoid models may overcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Saikosaponin D shows multi-target immunomodulatory potential as a microenvironment-priming agent. The current evidence is largely indirect and derived from non-hepatocellular carcinoma models. Future validation requires orthotopic studies, advanced nanoformulations, and formal synergy testing. This framework offers testable hypotheses rather than therapeutic claims.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1964907","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:49Z","timestamp":1790857429000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From cold to hot: the immunomodulatory framework of Saikosaponin D in hepatocellular carcinoma therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoyue","family":"Huang","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"Qin","sequence":"additional","affiliation":[{"name":"College of Acupuncture-Moxibustion and Orthopedics, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyue","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.02.005","article-title":"Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"35","author":"Sangro","year":"2024","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30011-5","article-title":"Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial","volume":"21","author":"Qin","year":"2020","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112534","article-title":"Activation of Wnt\/\u03b2-catenin signaling promotes immune evasion via the \u03b2-catenin\/IKZF1\/CCL5 axis in hepatocellular carcinoma","volume":"138","author":"Huang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.engmed.2025.100091","article-title":"Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis","volume":"2","author":"Liu","year":"2025","journal-title":"EngMedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110579","article-title":"Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K\/AKT\/mTOR pathway in murine models of pancreatic cancer","volume":"122","author":"Xu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.03.044","article-title":"Involvement of p53, nuclear factor kappaB and Fas\/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines","volume":"213","author":"Hsu","year":"2004","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.11669\/cpj.2018.19.006","article-title":"Effect and mechanism of saikosaponin D on autophagy by regulating mTORC pathway in human hepatocellular carcinoma cells","volume":"53","author":"Zongming","year":"2018","journal-title":"Chin Pharm J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.747987","article-title":"Systematic characterization and identification of saikosaponins in extracts from Bupleurum marginatum var. stenophyllum using UPLC-PDA-Q\/TOF-MS","volume":"9","author":"Liu","year":"2021","journal-title":"Front Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.37.2736","article-title":"Corticosterone secretion-inducing activity of saikosaponin metabolites formed in the alimentary tract","volume":"37","author":"Nose","year":"1989","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2012.06.010","article-title":"Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-\u03baB signaling pathway","volume":"14","author":"Lu","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00623","article-title":"Saikosaponin-d suppresses COX2 through p-STAT3\/C\/EBP\u03b2 signaling pathway in liver cancer: a novel mechanism of action","volume":"10","author":"Ren","year":"2019","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-13-263","article-title":"Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0\/g1 and g2\/m checkpoints of the cell cycle","volume":"13","author":"Wang","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000356648","article-title":"Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1\u03b1","volume":"33","author":"Wang","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/jox12040027","article-title":"Chemotherapeutic potential of saikosaponin D: Experimental evidence","volume":"12","author":"Manoharan","year":"2022","journal-title":"J Xenobiotics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.etap.2015.11.005","article-title":"Activation of Fas death receptor pathway and Bid in hepatocytes is involved in saikosaponin D induction of hepatotoxicity","volume":"41","author":"Zhang","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.37.3306","article-title":"Effects of saikosaponin metabolites on the hemolysis of red blood cells and their adsorbability on the cell membrane","volume":"37","author":"Nose","year":"1989","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2017.04.002","article-title":"Content decline of SERCA inhibitors saikosaponin a and d attenuates cardiotoxicity and hepatotoxicity of vinegar-baked Radix bupleuri","volume":"52","author":"Wang","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.11665\/j.issn.1000-5048.20220410","article-title":"Intestinal absorption mechanism of saikosaponin d in vitro and in vivo","volume":"53","author":"Yuanyue","year":"2022","journal-title":"J China Pharm Univ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70219","article-title":"Characterization of pharmacokinetics and oral bioavailability of saikosaponin A in rats using a validated UFLC-MS\/MS method","volume":"39","author":"Sun","year":"2025","journal-title":"BioMed Chromatogr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1775603","article-title":"Rewiring tumor-associated macrophages in hepatocellular carcinoma","volume":"17","author":"Han","year":"2026","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.12.006","article-title":"Life and death of tolerogenic dendritic cells","volume":"44","author":"Bourque","year":"2023","journal-title":"Trends Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elt028","article-title":"The IL-10\/STAT3-mediated anti-inflammatory response: recent developments and future challenges","volume":"12","author":"Hutchins","year":"2013","journal-title":"Brief Funct Genomics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01565-3","article-title":"Discovery of intrahepatic CD103+ cDC1\/CD8+ TRM protective immune axis against acetaminophen-induced acute liver injury","volume":"57","author":"Lee","year":"2025","journal-title":"Exp Mol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00441","article-title":"Characterization of antigen-presenting cell subsets in human liver-draining lymph nodes","volume":"10","author":"Boor","year":"2019","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70069","article-title":"Functional specialization and collaboration of cDC2 subsets in CD4+ T cell priming and differentiation","volume":"336","author":"Tatsumi","year":"2025","journal-title":"Immunol Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114996","article-title":"Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC","volume":"43","author":"Lu","year":"2024","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature20165","article-title":"S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate","volume":"540","author":"Tyrakis","year":"2016","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413095","article-title":"Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma","volume":"12","author":"Cai","year":"2025","journal-title":"Adv Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12964-025-02366-x","article-title":"Lactylation modification of HIF-1\u03b1 enhances its stability by blocking VHL recognition","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040273","article-title":"Central role of hypoxia-inducible factor-1\u03b1 in metabolic reprogramming of cancer cells: a review","volume":"103","author":"Zhu","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13811","article-title":"Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma","volume":"109","author":"Li","year":"2018","journal-title":"Cancer Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-018-3358-0","article-title":"Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKK\u03b2-AMPK-mTOR pathway in ADPKD cells","volume":"449","author":"Shi","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2190-4","article-title":"Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma","volume":"67","author":"Brown","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9602","article-title":"Epacadostat plus pembrolizumab in patients with advanced solid tumors: Phase I results from a multicenter, open-label phase I\/II trial (ECHO-202\/KEYNOTE-037)","volume":"36","author":"Mitchell","year":"2018","journal-title":"J Clin Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800630","article-title":"Indoleamine 2,3-dioxygenase 1: A promising therapeutic target in malignant tumor","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110792","article-title":"The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62","volume":"39","author":"Linares","year":"2022","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1620075","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma: origins, heterogeneity, and therapeutic implications","volume":"16","author":"Shi","year":"2025","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000489","article-title":"Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target","volume":"8","author":"Ding","year":"2024","journal-title":"Hepatol Commun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3349","article-title":"Estrogen receptor-\u03b2-dependent effects of saikosaponin-d on the suppression of oxidative stress-induced rat hepatic stellate cell activation","volume":"41","author":"Que","year":"2017","journal-title":"Int J Mol Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3778","article-title":"Immune exclusion-Wnt\/CTNNB1 class predicts resistance to immunotherapies in HCC","volume":"25","author":"Pinyol","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10238-023-01274-z","article-title":"WNT\/\u03b2-catenin regulatory roles on PD-(L)1 and immunotherapy responses","volume":"24","author":"Mortezaee","year":"2024","journal-title":"Clin Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091318","article-title":"PTEN alterations as a potential mechanism for tumor cell escape from PD-1\/PD-L1 inhibition","volume":"11","author":"Cretella","year":"2019","journal-title":"Cancers"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173069","article-title":"TP53 mutation-mediated immune evasion in cancer: Mechanisms and therapeutic implications","volume":"16","author":"Wang","year":"2024","journal-title":"Cancers"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10238-025-01851-4","article-title":"HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"26","author":"Shen","year":"2026","journal-title":"Clin Exp Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.53024","article-title":"Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cdd.2013.72","article-title":"Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists","volume":"21","author":"Yamazaki","year":"2014","journal-title":"Cell Death Differ"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b25-00787","article-title":"The dual role of saikosaponins in liver disease treatment: A comprehensive review of pharmacological activities and toxicological characteristics","volume":"49","author":"Zhu","year":"2026","journal-title":"Biol Pharm Bull"},{"key":"B74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2014.1568","article-title":"Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells","volume":"7","author":"Ying","year":"2014","journal-title":"Exp Ther Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.103","article-title":"Regulation of immunity and inflammation by hypoxia in immunological niches","volume":"17","author":"Taylor","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.08.002","article-title":"The role of HIF in immunity and inflammation","volume":"32","author":"McGettrick","year":"2020","journal-title":"Cell Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691134","article-title":"Lactate-dependent regulation of immune responses by dendritic cells and macrophages","volume":"12","author":"Manoharan","year":"2021","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi4191","article-title":"A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression","volume":"9","author":"Plebanek","year":"2024","journal-title":"Sci Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12885-019-5670-9","article-title":"Induction of tolerogenic dendritic cells by activated TGF-\u03b2\/Akt\/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells","volume":"19","author":"Zhong","year":"2019","journal-title":"BMC Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.015","article-title":"The functional impairment of HCC-infiltrating \u03b3\u03b4 T cells, partially mediated by regulatory T cells in a TGF\u03b2- and IL-10-dependent manner","volume":"58","author":"Yi","year":"2013","journal-title":"J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1431598","article-title":"Inhibition of IL-10 and TGF-\u03b2 receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells","volume":"14","author":"Thepmalee","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1609376113","article-title":"Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma","volume":"113","author":"Spranger","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123867","article-title":"Chemokine transfer by liver sinusoidal endothelial cells contributes to the recruitment of CD4+ T cells into the murine liver","volume":"10","author":"Neumann","year":"2015","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00624","article-title":"Saikosaponin A inhibits breast cancer by regulating Th1\/Th2 balance","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.894981","article-title":"Saikosaponin d alleviates liver fibrosis by negatively regulating the ROS\/NLRP3 inflammasome through activating the ER\u03b2 pathway","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i4.557","article-title":"Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats","volume":"13","author":"Dang","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S172042","article-title":"Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy","volume":"11","author":"Wu","year":"2018","journal-title":"Oncotargets Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.719836","article-title":"Vascular normalization: A new window opened for cancer therapies","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.908389","article-title":"Towards immunotherapy-induced normalization of the tumor microenvironment","volume":"10","author":"Melo","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101626","article-title":"Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy","volume":"5","author":"Mpekris","year":"2024","journal-title":"Cell Rep Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1696113","article-title":"The impact of metabolic reprogramming in hepatocellular carcinoma on T cell","volume":"16","author":"Liao","year":"2025","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1369\/00221554211056853","article-title":"Current perspectives on the immunosuppressive niche and role of fibrosis in hepatocellular carcinoma and the development of antitumor immunity","volume":"70","author":"Aoki","year":"2022","journal-title":"J Histochem Cytochem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12964-025-02101-6","article-title":"Cooperative Hedgehog\/GLI and JAK\/STAT signaling drives immunosuppressive tryptophan\/kynurenine metabolism via synergistic induction of IDO1 in skin cancer","volume":"23","author":"Elmer","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-024-00858-7","article-title":"Wnt\/\u03b2-catenin signaling pathway in liver biology and tumorigenesis","volume":"60","author":"Matsumoto","year":"2024","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.217","article-title":"Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells","volume":"4","author":"Wong","year":"2013","journal-title":"Cell Death Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30286","article-title":"Saikosaponin-d increases the radiosensitivity of hepatoma cells by adjusting cell autophagy","volume":"10","author":"Tian","year":"2019","journal-title":"J Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00662-3","article-title":"Adaptive immunity at the crossroads of autophagy and metabolism","volume":"18","author":"Metur","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.04.022","article-title":"Indoleamine-2,3-dioxygenase: An important controller in maintaining mesenchymal stem cell-mediated immunomodulatory homeostasis","volume":"15","author":"Hui","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1109737","article-title":"Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation","volume":"89","author":"Rotondo","year":"2011","journal-title":"J Leukocyte Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01684","article-title":"Tumor killing by CD4+ T cells is mediated via induction of inducible nitric oxide synthase-dependent macrophage cytotoxicity","volume":"9","author":"Fauskanger","year":"2018","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262412056","article-title":"iNOS in macrophage polarization: Pharmacological and regulatory insights","volume":"26","author":"Kang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7455494","article-title":"Saikosaponin-d attenuates Hashimoto\u2019s thyroiditis by regulating macrophage polarization","volume":"2022","author":"Du","year":"2022","journal-title":"J Immunol Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819849068","article-title":"Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR\/PI3K\/AKT\/mTOR pathway","volume":"18","author":"Lian","year":"2019","journal-title":"Technol Cancer Res T"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1429812","article-title":"Role of tumor-associated macrophages in hepatocellular carcinoma: Impact, mechanism, and therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133248","article-title":"The TGF-\u03b2 pathway: A pharmacological target in hepatocellular carcinoma","volume":"13","author":"Gonzalez-Sanchez","year":"2021","journal-title":"Cancers"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.165","article-title":"Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2025","journal-title":"Cancer Drug Resist"},{"key":"B110","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1089\/jmf.2013.2762","article-title":"Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells","volume":"16","author":"Chen","year":"2013","journal-title":"J Med Food"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520937163","article-title":"Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway","volume":"48","author":"Wu","year":"2020","journal-title":"J Int Med Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2020-0561","article-title":"Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-\u03b2\/NLRP3 inflammasome pathway","volume":"99","author":"Lin","year":"2021","journal-title":"Biochem Cell Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-025-05371-5","article-title":"Saikosaponin D modulates STAT3 and c-Myc expression in MDA-MB-231 cells: A comprehensive in silico and in vitro study","volume":"197","author":"Deivendran","year":"2025","journal-title":"Appl Biochem Biotechnol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60083","article-title":"STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients","volume":"123","author":"Vasquez-Dunddel","year":"2013","journal-title":"J Clin Invest"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12616","article-title":"Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway","volume":"148","author":"Ren","year":"2016","journal-title":"Immunology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13024","article-title":"Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10\/STAT3 signalling","volume":"26","author":"Wang","year":"2019","journal-title":"J Viral Hepat"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: Mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol Invest"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03625-4","article-title":"Hepatitis B virus X protein promotes the progression and immune escape of hepatocellular carcinoma by activating KLF16-C12orf49-PD-L1 axis","volume":"44","author":"Chen","year":"2025","journal-title":"Oncogene"},{"key":"B119","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1741398","article-title":"New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1139\/O07-010","article-title":"Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury","volume":"85","author":"Fan","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/ijmm.2024.5478","article-title":"Research progress on the molecular mechanisms of Saikosaponin D in various diseases (Review)","volume":"55","author":"Gu","year":"2024","journal-title":"Int J Mol Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/68846","article-title":"CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration","volume":"27","author":"Koper","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581582","article-title":"Lactate and lactylation in liver diseases: Energy metabolism, inflammatory immunity and tumor microenvironment","volume":"16","author":"Cheng","year":"2025","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2023040","article-title":"Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2\/glycolysis signaling","volume":"55","author":"He","year":"2023","journal-title":"Acta Biochim Biophys Sin"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03676-6","article-title":"Saikosaponin D suppresses esophageal squamous cell carcinoma via the PI3K-AKT signaling pathway","volume":"398","author":"Duan","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.10.175","article-title":"Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor","volume":"338","author":"Leung","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049340","article-title":"Toll-like receptor-targeted anti-tumor therapies: Advances and challenges","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-611426","article-title":"Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: Impact of immune activation and cereblon targets","volume":"125","author":"Sehgal","year":"2015","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1038\/s41467-021-26477-4","article-title":"Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217913","article-title":"Hypoxia and immunometabolism in the tumor microenvironment: Insights into mechanisms and therapeutic potential","volume":"631","author":"Wu","year":"2025","journal-title":"Cancer Lett"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1158\/2159-8290.CD-21-0425","article-title":"Overcoming PD-1 blockade resistance with CpG-A toll-like receptor 9 agonist Vidutolimod in patients with metastatic melanoma","volume":"11","author":"Ribas","year":"2021","journal-title":"Cancer Discov"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000209","article-title":"Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma","volume":"7","author":"Yamada","year":"2023","journal-title":"Hepatol Commun"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155945","article-title":"Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance","volume":"133","author":"Luo","year":"2024","journal-title":"Phytomedicine"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00552-2","article-title":"Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy","volume":"43","author":"Zhu","year":"2020","journal-title":"Cell Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1964907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:53Z","timestamp":1790857433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1964907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":139,"alternative-id":["10.3389\/fimmu.2026.1964907"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1964907","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1964907"}}